British Journal of Cancer - Table of Contents alert Volume 105 Issue 3

TABLE OF CONTENTS Volume 105, Issue 3 (329-467) Published online 26 July 2011 In this issue Minireview Clinical Studies Translational Therapeutics Molecular Diagnostics Epidemiology Letters to the Editor Also new today Advance online publication Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Latest research published in BJC makes front page of the BBC news Weight is the biggest factor affecting the level of sex hormones that increase breast cancer risk in post menopausal women, according to new research published in BJC. View article here: Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies   Minireview Top Oncogenic AKTivation of translation as a therapeutic target A C Hsieh, M L Truitt and D Ruggero Br J Cancer 2011 105: 329-336; advance online publication, July 19, 2011; 10.1038/bjc.2011.241 Abstract | Full Text Clinical Studies Top Self-sampling and HPV testing or ordinary Pap-smear in women not regularly attending screening: a randomised study I Wikström, M Lindell, K Sanner and E Wilander Br J Cancer 2011 105: 337-339; advance online publication, July 5, 2011; 10.1038/bjc.2011.236 Abstract | Full Text A telephone survey of cancer awareness among frontline staff: informing training needs N Cook, A Hart, K Nuttall, K Simpson, N Turnill, C Grant-Pearce, P Damms, V Allen, K Slade and P Dey Br J Cancer 2011 105: 340-345; advance online publication, July 12, 2011; 10.1038/bjc.2011.258 Abstract | Full Text A randomised, phase II study of intetumumab, an anti-αv-integrin mAb, alone and with dacarbazine in stage IV melanoma S O'Day, A Pavlick, C Loquai, D Lawson, R Gutzmer, J Richards, D Schadendorf, J A Thompson, R Gonzalez, U Trefzer, P Mohr, C Ottensmeier, D Chao, B Zhong, C J de Boer, C Uhlar, D Marshall, M E Gore, Z Lang, W Hait and P Ho on the behalf of the CNTO 95 Investigators Br J Cancer 2011 105: 346-352; advance online publication, July 12, 2011; 10.1038/bjc.2011.183 Abstract | Full Text Sorafenib and dacarbazine as first-line therapy for advanced melanoma: phase I and open-label phase II studies T Eisen, R Marais, A Affolter, P Lorigan, C Robert, P Corrie, C Ottensmeier, C Chevreau, D Chao, P D Nathan, T Jouary, M Harries, S Negrier, E Montegriffo, T Ahmad, I Gibbens, M G James, U P Strauss, S Prendergast and M E Gore Br J Cancer 2011 105: 353-359; advance online publication, July 12, 2011; 10.1038/bjc.2011.257 Abstract | Full Text Carboplatin–paclitaxel-induced leukopenia and neuropathy predict progression-free survival in recurrent ovarian cancer C K Lee, H Gurney, C Brown, R Sorio, N Donadello, G Tulunay, W Meier, M Bacon, J Maenpaa, E Petru, N Reed, V Gebski, E Pujade-Lauraine, S Lord, R J Simes and M Friedlander Br J Cancer 2011 105: 360-365; advance online publication, July 12, 2011; 10.1038/bjc.2011.256 Abstract | Full Text T-bet expression in intratumoral lymphoid structures after neoadjuvant trastuzumab plus docetaxel for HER2-overexpressing breast carcinoma predicts survival S Ladoire, L Arnould, G Mignot, L Apetoh, C Rébé, F Martin, P Fumoleau, B Coudert and F Ghiringhelli Br J Cancer 2011 105: 366-371; advance online publication, July 12, 2011; 10.1038/bjc.2011.261 Abstract | Full Text Translational Therapeutics Top Identification and evaluation of a potent novel ATR inhibitor, NU6027, in breast and ovarian cancer cell lines A Peasland, L-Z Wang, E Rowling, S Kyle, T Chen, A Hopkins, W A Cliby, J Sarkaria, G Beale, R J Edmondson and N J Curtin Br J Cancer 2011 105: 372-381; advance online publication, July 5, 2011; 10.1038/bjc.2011.243 Abstract | Full Text Antitumour efficacy of MEK inhibitors in human lung cancer cells and their derivatives with acquired resistance to different tyrosine kinase inhibitors F Morgillo, T Cascone, E D'Aiuto, E Martinelli, T Troiani, P Saintigny, R De Palma, J V Heymach, L Berrino, C Tuccillo and F Ciardiello Br J Cancer 2011 105: 382-392; advance online publication, July 12, 2011; 10.1038/bjc.2011.244 Abstract | Full Text In vitro and in vivo inhibitory effect of three Cox-2 inhibitors and epithelial-to-mesenchymal transition in human bladder cancer cell lines Z Adhim, T Matsuoka, T Bito, K Shigemura, K-M Lee, M Kawabata, M Fujisawa, K Nibu and T Shirakawa Br J Cancer 2011 105: 393-402; advance online publication, July 12, 2011; 10.1038/bjc.2011.262 Abstract | Full Text Molecular Diagnostics Top KRAS mutations detected by the amplification refractory mutation system–Scorpion assays strongly correlate with therapeutic effect of cetuximab H Bando, T Yoshino, K Tsuchihara, N Ogasawara, N Fuse, T Kojima, M Tahara, M Kojima, K Kaneko, T Doi, A Ochiai, H Esumi and A Ohtsu Br J Cancer 2011 105: 403-406; advance online publication, July 5, 2011; 10.1038/bjc.2011.247 Abstract | Full Text Differential roles of STAT3 depending on the mechanism of STAT3 activation in gastric cancer cells W Okamoto, I Okamoto, T Arao, K Yanagihara, K Nishio and K Nakagawa Br J Cancer 2011 105: 407-412; advance online publication, July 5, 2011; 10.1038/bjc.2011.246 Abstract | Full Text High FOXP3+ regulatory T-cell density in the sentinel lymph node is associated with downstream non-sentinel lymph-node metastasis in gastric cancer H E Lee, D J Park, W H Kim, H H Kim and H S Lee Br J Cancer 2011 105: 413-419; advance online publication, July 5, 2011; 10.1038/bjc.2011.248 Abstract | Full Text EGFR gene amplification is related to adverse clinical outcomes in cervical squamous cell carcinoma, making the EGFR pathway a novel therapeutic target K Iida, K Nakayama, M T Rahman, M Rahman, M Ishikawa, A Katagiri, S Yeasmin, Y Otsuki, H Kobayashi, S Nakayama and K Miyazaki Br J Cancer 2011 105: 420-427; advance online publication, July 5, 2011; 10.1038/bjc.2011.222 Abstract | Full Text Reduced association of anti-apoptotic protein Mcl-1 with E3 ligase Mule increases the stability of Mcl-1 in breast cancer cells S Pervin, A Tran, L Tran, R Urman, M Braga, G Chaudhuri and R Singh Br J Cancer 2011 105: 428-437; advance online publication, July 5, 2011; 10.1038/bjc.2011.242 Abstract | Full Text Epidemiology Top Second to fourth digit ratio (2D:4D) and prostate cancer risk in the Melbourne Collaborative Cohort Study D C Muller, G G Giles, J T Manning, J L Hopper, D R English and G Severi Br J Cancer 2011 105: 438-440; advance online publication, July 5, 2011; 10.1038/bjc.2011.253 Abstract | Full Text Dietary cadmium exposure and risk of epithelial ovarian cancer in a prospective cohort of Swedish women B Julin, A Wolk and A Åkesson Br J Cancer 2011 105: 441-444; advance online publication, June 21, 2011; 10.1038/bjc.2011.238 Abstract | Full Text Age- and sex-standardised prevalence rates of fatigue in a large hospital-based sample of cancer patients S Singer, S Kuhnt, R Zwerenz, K Eckert, D Hofmeister, A Dietz, J Giesinger, J Hauss, K Papsdorf, S Briest and A Brown Br J Cancer 2011 105: 445-451; advance online publication, July 12, 2011; 10.1038/bjc.2011.251 Abstract | Full Text Exposure to cyclooxygenase-2 inhibitors and risk of cancer: nested case–control studies Y Vinogradova, C Coupland and J Hippisley-Cox Br J Cancer 2011 105: 452-459; advance online publication, July 12, 2011; 10.1038/bjc.2011.252 Abstract | Full Text What is the lifetime risk of developing cancer?: the effect of adjusting for multiple primaries P D Sasieni, J Shelton, N Ormiston-Smith, C S Thomson and P B Silcocks Br J Cancer 2011 105: 460-465; advance online publication, July 19, 2011; 10.1038/bjc.2011.250 Abstract | Full Text Letters to the Editor Top Comment on ‘Hand pattern indicates risk of prostate cancer’ M Cheema and A Sharif Br J Cancer 2011 105: 466; 10.1038/bjc.2011.232 Abstract | Full Text Reply: ‘Hand pattern indicates risk of prostate cancer’ A A Rahman, A Lophatananon, S Stewart-Brown, D Harriss, J Anderson, T Parker, D Easton, Z Kote-Jarai, R Pocock, D Dearnaley, M Guy, L O'Brien, R A Wilkinson, A L Hall, E Sawyer, E Page, J-F Liu, R A Eeles and K-R Muir The UK Genetic Prostate Cancer Study Collaborators, British Association of Urological Surgeons' Section of Oncology Br J Cancer 2011 105: 467; 10.1038/bjc.2011.233 Abstract | Full Text Advertisement Increasing the visibility of your research...BJC OPEN Authors may choose to have their original research article made open access on publication (by paying a one off fee) under BJC OPEN. Visit www.bjcancer.com for more information.   Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2011 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.